Trial · NCT02012959
Results by group15
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 15 of 15
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change In Serum Sodium Concentration For Responders | Responder - Late Withdrawal | -4.0 | Standard Deviation 4.2 | mEq/L | |
| Change In Serum Sodium Concentration For Responders | Responder - Early Withdrawal | -1.0 | Standard Deviation 1.0 | mEq/L | |
| Change In Serum Sodium Concentration During Treatment Phase A | Phase A: All Participants | Day 1: 24 hours Post Dose | 1 | Standard Deviation 3 | mEq/L |
| Change In Serum Sodium Concentration During Treatment Phase A | Phase A: All Participants | Day 2: 24 hours Post Dose | 3.4 | Standard Deviation 4.8 | mEq/L |
| Change In Serum Sodium Concentration During Treatment Phase A | Phase A: All Participants | Day 2a: 24 hours Post Dose | 2.3 | Standard Deviation 2.1 | mEq/L |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 1: 0-6 hours | -1 | Standard Deviation 505 | mL |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 1: 6-12 hours | -261 | Standard Deviation 533 | mL |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 1: 12-18 hours | -36 | Standard Deviation 253 | mL |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 1: 18-24 hours | 31 | Standard Deviation 344 | mL |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 1: 0-24 hours | -268 | Standard Deviation 849 | mL |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 2: 0-6 hours | -101 | Standard Deviation 376 | mL |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 2: 6-12 hours | 6 | Standard Deviation 513 | mL |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 2: 12-18 hours | -45 | Standard Deviation 400 | mL |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 2: 18-24 hours | -21 | Standard Deviation 191 | mL |
| Fluid Balance (Intake Minus Output) During Treatment Phase A | Phase A: All Participants | Day 2: 0-24 hours | -160 | Standard Deviation 733 | mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02012959/results